Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home CEO Interviews

Virios Therapeutics (VIRI) CEO Greg Duncan Exclusive Interview on Global Market Bulletin TV

by Global Market Bulletin
February 16, 2023
in CEO Interviews
0
Virios Greg Duncan VIRI Interview Global Market Bulletin
3
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Virios Therapeutics, a cutting-edge biotechnology company with its headquarters in San Diego, California, has been making great strides towards advancing the treatment of chronic diseases such as fibromyalgia with their patented combination antiviral therapies. Recently, Greg Duncan, Chairman and CEO of Virios Therapeutics (NASDAQ: VIRI) and a top executive in the biotech sector, was featured on Global Market Bulletin TV for an exclusive interview discussing his work at the company and their mission to create groundbreaking treatments.

You might also like

International Land Alliance (ILAL) President Frank Ingrande Exclusive Video Interview with Global Market Bulletin TV

NEXGEL’s Adam Levy: An Exclusive Interview on Global Market Bulletin TV (NXGL)

iSpecimen CFO & Interim-CEO Tracy Curley Video Interview with Global Market Bulletin TV

Mr. Duncan stressed the importance of the end-of-Phase 2 meeting request with the U.S Food and Drug Administration (FDA) to progress IMC-1 into Phase 3 development as a treatment for Fibromyalgia that is scheduled for mid March 2023. Furthermore, he informed viewers about Virio’s partnership with Intervene Immune’s for enrollment in exploratory Long COVID trial initiatives aimed at managing symptoms related to post-Acute Sequelae of COVID-19 (PASC).

Greg Duncan boasts an impressive career in biotechnology that includes past roles as President and Chief Executive Officer at Celtaxsys Inc., an anti-inflammatory treatments development firm; various executive level positions within Pfizer; Chairmanship of Biotie Therapeutics; and many more industry roles. His expertise allowed him to lead teams responsible for highly successful launches of multiple pharmaceutical products such as Lipitor, Zoloft, Celebrex, Aricept – to name just a few – marking him out as a leader in drug development organizations. Mr. Duncan holds an MBA from Emory University in Atlanta and undergraduate degree in Economics from State University of New York in Albany.

Virios Therapeutics focuses primarily on developing novel antiviral treatments with their leading experimental prospect being IMC-1 – patented fusion between famciclovir and celecoxib designed to inhibit infection by herpes viruses related to chronic illness like FM – which has been given fast track status by the FDA. In addition, the company is expanding its research into developing IMC-2 (valacyclovir and celecoxib) as a potential treatment for addressing fatigue, sleeplessness, attention deficits, pain, autonomic dysfunction and anxiety presented by Long-COVID or PASC.

If you’re looking for more information about Virios Therapeutics’ cutting edge breakthroughs or would like to learn more about Chairman & CEO Greg Duncan’s stellar career make sure to visit the official website at https://www.virios.com/

Tags: CEO Video InterviewGlobal Market Bulletin TVVirios Therapeutics (NASDAQ: VIRI)
Share1Tweet1
Global Market Bulletin

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions.

Recommended For You

International Land Alliance (ILAL) President Frank Ingrande Exclusive Video Interview with Global Market Bulletin TV

by Global Market Bulletin
January 31, 2023
0
International Land Alliance ILAL President Frank Ingrande Exclusive Video Interview with Global Market Bulletin TV

International Land Alliance (ILAL) President, Frank A. Ingrande, was the guest on the latest episode of Global Market Bulletin TV. Host Leyla Gulen welcomed Mr. Ingrande for an...

Read more

NEXGEL’s Adam Levy: An Exclusive Interview on Global Market Bulletin TV (NXGL)

by Global Market Bulletin
January 19, 2023
0
NEXGEL CEO Adam Levy Exclusive Interview Global Market Bulletin TV

On this episode of Global Market Bulletin TV, esteemed guest Mr. Adam Levy - CEO, President, and Director at NEXGEL (NASDAQ: NXGL) - joins Leyla Gulen to give...

Read more

iSpecimen CFO & Interim-CEO Tracy Curley Video Interview with Global Market Bulletin TV

by Global Market Bulletin
December 5, 2022
0
iSpecimen CFO Interim-CEO Tracy Curley Video Interview

Tracy Curley, Chief Financial Officer and interim-CEO of iSpecimen (NASDAQ: ISPC), joins host Leyla Gulen to discuss the launch of their new self-service Open Feasibilities Dashboard on Marketplace....

Read more

CEL-SCI CEO Geert Kersten Video Interview with Global Market Bulletin TV

by Global Market Bulletin
November 23, 2022
0
Global Market Bulletin TV Interview CEL-SCI CEO Geert Kersten

In this episode of Global Market Bulletin TV, host Leyla Gulen interviews CEL-SCI Corporation CEO Geert Kersten on the latest company developments and what investors can expect in...

Read more

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us

RECENT POSTS

  • Virios Therapeutics (VIRI) CEO Greg Duncan Exclusive Interview on Global Market Bulletin TV
  • International Land Alliance (ILAL) President Frank Ingrande Exclusive Video Interview with Global Market Bulletin TV
  • NEXGEL’s Adam Levy: An Exclusive Interview on Global Market Bulletin TV (NXGL)

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?